Protalix BioTherapeutics (PLX) Reports Q2 Loss of $0.11/Share
Tweet
Share
E-mailGet Alerts PLX Hot Sheet
Price: $2.34 +2.18%
Financial Fact:
GROSS PROFIT (LOSS): 422K
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
GROSS PROFIT (LOSS): 422K
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
Protalix BioTherapeutics (NYSE: PLX) reported Q2 EPS of ($0.11), versus ($0.05) reported last year. Revenue for the quarter came in at $1.77 million, versus $1.34 million reported last year.
For earnings history and earnings-related data on Protalix BioTherapeutics (PLX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- La-Z-Boy (LZB) Misses Q1 EPS by 6c, Misses on Revenue; Offers Weak Q2 Revenue Guidance
- Evolution Petroleum launches stock offering to fund Permian Basin deal
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
